Advanced quench correction model for quantitative offline radioactivity counting in in vivo drug metabolism studies

A novel workflow for quantification of a drug and its metabolites in in vivo studies has been developed in the context of a radiolabeled human mass balance study. Samples are analyzed with ultra-high-performance liquid chromatography, and fractions are collected in a 384-well plate, which is subjected to offline counting, providing improved detection limits over online radioactivity detection. We discuss an advanced strategy to account for signal suppression or quenching, which significantly affected results in the offline counting of feces and urine samples in the selected case example, to provide more accurate quantification. The new quench model fits 2 data sets from 384-well plates with the actual matrices present to perform counting efficiency correction. Improved results were obtained over the existing approach, where a generic quench curve is defined by only a limited number of points made from a dilution series of a quenching agent. To account for outliers, a robust quartic model was applied. The new model effectively describes matrix-induced quenching and corrects for this, resulting in correct profiles with improved overall recovery as corroborated by comparison with online radioactivity detection and liquid scintillation counting, and can generically be applied postacquisition. The strategy was applied to all 36 fecal extracts from a human absorption, distribution, metabolism, and excretion study, where half of the samples present less than 20,000 disintegrations per min/mL, increasing the average column recovery (sum of individually quantified peaks relative to the total injected radioactivity) to >85%. SIGNIFICANCE STATEMENT: To improve interpretation in radiolabeled absorption, distribution, metabolism, and excretion studies, a matrix-based quench correction model is developed. It compensates for matrix-induced signal suppression when analyzing in vivo samples via offline radioactivity counting. It greatly improves data quality and enables accurate assessment of the true significance of detected metabolites.

Authors

Institutions

Publication Details

Journal
Drug Metabolism and Disposition
Published
2025-11-25
DOI
https://doi.org/10.1016/j.dmd.2025.100206
Citations
1
Primary Topic
Pharmacogenetics and Drug Metabolism
Type
article
Field-Weighted Citation Impact
1.56
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Advanced quench correction model for quantitative offline radioactivity counting in in vivo drug metabolism studies

Fetene Tekle, Filip Cuyckens, Cis Van Looveren, Sam Wouters
1 citations
Drug Metabolism and Disposition
Pharmacogenetics and Drug Metabolism
1.56
article

Advanced quench correction model for quantitative offline radioactivity counting in in vivo drug metabolism studies

Fetene Tekle, Filip Cuyckens, Cis Van Looveren, Sam Wouters
article en
1 citations

Abstract

A novel workflow for quantification of a drug and its metabolites in in vivo studies has been developed in the context of a radiolabeled human mass balance study. Samples are analyzed with ultra-high-performance liquid chromatography, and fractions are collected in a 384-well plate, which is subjected to offline counting, providing improved detection limits over online radioactivity detection. We discuss an advanced strategy to account for signal suppression or quenching, which significantly affected results in the offline counting of feces and urine samples in the selected case example, to provide more accurate quantification. The new quench model fits 2 data sets from 384-well plates with the actual matrices present to perform counting efficiency correction. Improved results were obtained over the existing approach, where a generic quench curve is defined by only a limited number of points made from a dilution series of a quenching agent. To account for outliers, a robust quartic model was applied. The new model effectively describes matrix-induced quenching and corrects for this, resulting in correct profiles with improved overall recovery as corroborated by comparison with online radioactivity detection and liquid scintillation counting, and can generically be applied postacquisition. The strategy was applied to all 36 fecal extracts from a human absorption, distribution, metabolism, and excretion study, where half of the samples present less than 20,000 disintegrations per min/mL, increasing the average column recovery (sum of individually quantified peaks relative to the total injected radioactivity) to >85%. SIGNIFICANCE STATEMENT: To improve interpretation in radiolabeled absorption, distribution, metabolism, and excretion studies, a matrix-based quench correction model is developed. It compensates for matrix-induced signal suppression when analyzing in vivo samples via offline radioactivity counting. It greatly improves data quality and enables accurate assessment of the true significance of detected metabolites.

Drug Metabolism and DispositionVol. 54(1)
Johnson & Johnson (United States) (US), Johnson Engineering (United States) (US), Johnson & Johnson (Brazil) (BR)
Openalex Percentile: Top 14%
Pharmacogenetics and Drug Metabolism
1.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.